vs
CEMTREX INC（CETX）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是CEMTREX INC的1.2倍（$19.6M vs $16.1M），CEMTREX INC净利率更高（-127.4% vs -177.4%，领先50.0%），CEMTREX INC同比增速更快（17.4% vs -11.5%），CEMTREX INC自由现金流更多（$-1.1M vs $-23.1M），过去两年CEMTREX INC的营收复合增速更高（-3.0% vs -12.2%）
Cemtrex Inc是一家多元化工业科技企业，主营物联网工业自动化解决方案、环境监测系统及数字办公工具，核心客户主要来自北美、欧洲的制造、工业及商业领域。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CETX vs LAB — 直观对比
营收规模更大
LAB
是对方的1.2倍
$16.1M
营收增速更快
CETX
高出28.9%
-11.5%
净利率更高
CETX
高出50.0%
-177.4%
自由现金流更多
CETX
多$22.0M
$-23.1M
两年增速更快
CETX
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.1M | $19.6M |
| 净利润 | $-20.6M | $-34.7M |
| 毛利率 | 34.8% | 48.5% |
| 营业利润率 | -17.4% | -168.5% |
| 净利率 | -127.4% | -177.4% |
| 营收同比 | 17.4% | -11.5% |
| 净利润同比 | 28.5% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CETXLAB
| Q4 25 | $16.1M | — | ||
| Q3 25 | $18.5M | $19.6M | ||
| Q2 25 | $17.0M | $21.8M | ||
| Q1 25 | $27.3M | $40.8M | ||
| Q4 24 | $13.7M | — | ||
| Q3 24 | $18.1M | $22.1M | ||
| Q2 24 | $14.7M | $22.5M | ||
| Q1 24 | $17.2M | $45.5M |
净利润CETXLAB
| Q4 25 | $-20.6M | — | ||
| Q3 25 | $-3.4M | $-34.7M | ||
| Q2 25 | $-4.5M | $-33.5M | ||
| Q1 25 | $8.4M | $-26.0M | ||
| Q4 24 | $-28.8M | — | ||
| Q3 24 | $4.4M | $-26.9M | ||
| Q2 24 | $-9.0M | $-45.7M | ||
| Q1 24 | $-1.5M | $-32.2M |
毛利率CETXLAB
| Q4 25 | 34.8% | — | ||
| Q3 25 | 38.0% | 48.5% | ||
| Q2 25 | 43.4% | 48.8% | ||
| Q1 25 | 44.6% | 48.4% | ||
| Q4 24 | 41.5% | — | ||
| Q3 24 | 41.8% | 54.9% | ||
| Q2 24 | 40.0% | 46.1% | ||
| Q1 24 | 40.4% | 53.1% |
营业利润率CETXLAB
| Q4 25 | -17.4% | — | ||
| Q3 25 | -6.4% | -168.5% | ||
| Q2 25 | -3.8% | -118.1% | ||
| Q1 25 | 16.9% | -80.8% | ||
| Q4 24 | -16.6% | — | ||
| Q3 24 | -1.8% | -120.9% | ||
| Q2 24 | -21.6% | -134.5% | ||
| Q1 24 | -6.0% | -132.2% |
净利率CETXLAB
| Q4 25 | -127.4% | — | ||
| Q3 25 | -18.1% | -177.4% | ||
| Q2 25 | -26.8% | -153.7% | ||
| Q1 25 | 30.8% | -63.8% | ||
| Q4 24 | -209.3% | — | ||
| Q3 24 | 24.1% | -122.0% | ||
| Q2 24 | -61.2% | -203.3% | ||
| Q1 24 | -8.6% | -70.6% |
每股收益（稀释后）CETXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.5M | $129.4M |
| 总债务越低越好 | $12.8M | — |
| 股东权益账面价值 | $29.1M | $399.7M |
| 总资产 | $60.3M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资CETXLAB
| Q4 25 | $20.5M | — | ||
| Q3 25 | $5.0M | $129.4M | ||
| Q2 25 | $7.0M | $158.6M | ||
| Q1 25 | $4.5M | $150.9M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $3.9M | $210.6M | ||
| Q2 24 | $6.5M | $269.8M | ||
| Q1 24 | $2.9M | $287.1M |
总债务CETXLAB
| Q4 25 | $12.8M | — | ||
| Q3 25 | $13.5M | — | ||
| Q2 25 | $18.3M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $18.7M | — | ||
| Q3 24 | $18.0M | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | $21.6M | $55.0M |
股东权益CETXLAB
| Q4 25 | $29.1M | — | ||
| Q3 25 | $8.7M | $399.7M | ||
| Q2 25 | $3.6M | $424.5M | ||
| Q1 25 | $6.4M | $454.6M | ||
| Q4 24 | $-1.6M | — | ||
| Q3 24 | $4.7M | $489.3M | ||
| Q2 24 | $48.0K | $510.3M | ||
| Q1 24 | $4.7M | $577.3M |
总资产CETXLAB
| Q4 25 | $60.3M | — | ||
| Q3 25 | $47.8M | $539.6M | ||
| Q2 25 | $47.0M | $557.0M | ||
| Q1 25 | $46.2M | $579.6M | ||
| Q4 24 | $46.7M | — | ||
| Q3 24 | $44.1M | $681.5M | ||
| Q2 24 | $43.8M | $708.7M | ||
| Q1 24 | $47.2M | $777.7M |
负债/权益比CETXLAB
| Q4 25 | 0.44× | — | ||
| Q3 25 | 1.55× | — | ||
| Q2 25 | 5.07× | — | ||
| Q1 25 | 2.94× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.82× | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | 4.60× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-891.9K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | -6.7% | -118.1% |
| 资本支出强度资本支出/营收 | 1.1% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-721.5K | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CETXLAB
| Q4 25 | $-891.9K | — | ||
| Q3 25 | $-3.3M | $-22.2M | ||
| Q2 25 | $1.8M | $-20.7M | ||
| Q1 25 | $2.8M | $-30.3M | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.9M | $-27.9M | ||
| Q2 24 | $675.8K | $-39.0M | ||
| Q1 24 | $386.8K | $-62.5M |
自由现金流CETXLAB
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $-3.7M | $-23.1M | ||
| Q2 25 | $1.7M | $-22.6M | ||
| Q1 25 | $2.4M | $-35.3M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-2.7M | $-30.1M | ||
| Q2 24 | $601.7K | $-41.0M | ||
| Q1 24 | $322.2K | $-63.3M |
自由现金流率CETXLAB
| Q4 25 | -6.7% | — | ||
| Q3 25 | -20.2% | -118.1% | ||
| Q2 25 | 10.2% | -103.6% | ||
| Q1 25 | 8.7% | -86.6% | ||
| Q4 24 | -15.5% | — | ||
| Q3 24 | -15.1% | -136.4% | ||
| Q2 24 | 4.1% | -182.2% | ||
| Q1 24 | 1.9% | -138.9% |
资本支出强度CETXLAB
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.7% | 4.5% | ||
| Q2 25 | 0.4% | 8.7% | ||
| Q1 25 | 1.6% | 12.4% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 4.8% | 10.2% | ||
| Q2 24 | 0.5% | 8.6% | ||
| Q1 24 | 0.4% | 1.7% |
现金转化率CETXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.43× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CETX
| Industrial Services | $10.6M | 66% |
| Security | $5.5M | 34% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
